Accure Labs Private Limited, a active private limited company, was established on 25 August 2004 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232DL2004PTC128617. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹16.10 Cr and a paid-up capital of ₹0.14 M.
It upholds a compliant status. Employing 17 professional, Its leadership includes Amitabh Ganguli (Director), Sandeep Sharadaprasad Srivastava (Director), Ratan Capoor (Director). Past directors included Amitabh Ganguli, Brij Sarin, Sandeep Sharadaprasad Srivastava. It holds ₹6.33 Cr open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.1406A, 14Th Floor Building No. 89, Hemkunth Chamber, Nehru, Place, New Delhi, Delhi, 110019.
U24232DL2004PTC128617
128617
25 August 2004
₹16.10 Cr
₹0.14 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Accure Labs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amitabh Ganguli | Director | 25 Apr 2019 | Current |
| Sandeep Sharadaprasad Srivastava | Director | 17 Jul 2020 | Current |
| Ratan Capoor | Director | 07 Oct 2022 | Current |
| Jagrato Roy | Director | 29 May 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2019 | Past |
| Pramod Abcsdd | Director | 12 Mar 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Director | 30 Nov 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 01 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Accure Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 78.32% increase. The company also saw a substantial improvement in profitability, with a 27.77% increase in profit. The company's net worth Soared by an impressive increase of 37.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Accure Labs had a promoter holding of 82.50% and a public holding of 17.50%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹63,250,000.00
₹20,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Aug 2019 | The Hongkong And Shanghai Banking Corporation Limited | ₹6.33 Cr | Open |
| 28 Apr 2023 | Hdfc Bank Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Accure Labs has a workforce of 17 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Accure Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accure Labs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 6.33 Cr registered on 13 Aug 2019 with Charge ID 100283032 was modified on 21 Aug 2025. was documented.
The activity Accure Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge registered on 28 Apr 2023 via Charge ID 100723030 with Hdfc Bank Limited was fully satisfied on 01 Jun 2024. was completed.
Progress on Accure Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100723030 was registered on 28 Apr 2023. was recorded as a recent event.
Progress on Ratan Capoor was appointed as a Director was appointed as a Director on 07 Oct 2022 & has been associated with this company since 3 years 2 months . was documented.
The CIN of Accure Labs Private Limited is U24232DL2004PTC128617.
Accure Labs Private Limited is headquartered at Flat No.1406A, 14Th Floor Building No. 89, Hemkunth Chamber, Nehru, Place, New Delhi, Delhi, 110019.
Accure Labs Private Limited was incorporated on 25 August 2004.
The current directors of Accure Labs Private Limited are
The primary industry of Accure Labs Private Limited is Trade.
Accure Labs Private Limited is unlisted.
The authorized capital of Accure Labs Private Limited is ₹16.10 Cr, and the paid-up capital is ₹0.14 M.
The compliance status of Accure Labs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX